Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Renalert
AddedFeb 18, 2024
UpdatedJun 18, 2026
Renalert

Renalert

Renalert: Real-time kidney monitoring for early detection of acute injury, analyzing urine output, blood pressure, and oxygenation.

HQ
Baltimore, MD, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Renalert, founded in Baltimore, is dedicated to preventing deaths from Acute Kidney Injury (AKI) through its innovative real-time monitoring system. The company's core mission is to provide early detection of AKI by analyzing a patient’s urine output, blood pressure, and oxygenation status. This proactive approach aims to address the high mortality rate associated with AKI, which surpasses that of several major diseases combined. Renalert's market focus includes hospitals and healthcare providers seeking advanced solutions for patient monitoring and kidney health management.

Notable affiliations include Johns Hopkins University, which supports Renalert's research and development efforts. The company has garnered attention for its significant contributions to healthcare technology, particularly in the early detection and management of kidney-related conditions. Renalert's impact is evident in its potential to save lives by enabling timely medical interventions, thereby reducing the mortality rate associated with AKI.

Renalert - Similar Companies

RenalGuard Solutions logo

RenalGuard Solutions

renalguard.com

Nephrosant logo

Nephrosant

River 3 Renal logo

River 3 Renal

Vasc-Alert logo

Vasc-Alert

vasc-alert.com

Rejuvenate Kidney Transplant Solutions logo

Rejuvenate Kidney Transplant Solutions

River 2 Renal logo

River 2 Renal

Bright Uro logo

Bright Uro

brighturo.com

Reset Kidney Health logo

Reset Kidney Health

Alertgy logo

Alertgy

alertgy.com

Specialty Renal Products logo

Specialty Renal Products

Relavo logo

Relavo

relavomedical.com

Kantum Pharma logo

Kantum Pharma

Pure Life Renal logo

Pure Life Renal

plrenal.com

Evergreen Nephrology logo

Evergreen Nephrology

Starling logo

Starling

Renalert - Quick Facts

Who are Renalert's competitors?

Companies similar to Renalert include RenalGuard Solutions, Nephrosant, River 3 Renal and Vasc-Alert.

When was Renalert founded?

Renalert was founded in 2016.

Where is Renalert's headquarters located?

Renalert's headquarters is located in Baltimore, MD, US.

When was Renalert's last funding round?

Renalert's most recent funding round was for $25k (USD) in September 2019.

How much has Renalert raised to-date?

As of Sep 28, 2019, Renalert has raised a total of $175k (USD).

How many employees does Renalert have?

Renalert has 1 employee as of Feb 4, 2024.

Renalert - Classification

Industry
  • Hardware
Technology
  • Analytics
  • HealthTech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Kidney Monitoring
Tags
  • Healthcare
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research